Chondrocyte therapeutic delivery system

Details Chondrocyte therapeutic delivery system Chondrocyte therapeutic delivery system

2011-04-19

2011-04-19

Ton, Thaian N (Department: 1632)

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

C424S093210

Reexamination Certificate

active

07927599

ABSTRACT:
Systems and methods for modifying the environment of target cell using genetically altered chondrocytes are provided. The genetically engineered chondrocytes can be used to express a therapeutic agent in a subject, including in an environment typically associated with chondrocytes and in an environment not typically associated with chondrocytes.

REFERENCES:
patent: 4105034 (1978-08-01), Shalaby et al.
patent: 4130639 (1978-12-01), Shalaby et al.
patent: 4140678 (1979-02-01), Shalaby et al.
patent: 4141087 (1979-02-01), Shalaby et al.
patent: 4205399 (1980-06-01), Shalaby et al.
patent: 4208511 (1980-06-01), Shalaby et al.
patent: 4332255 (1982-06-01), Hakim et al.
patent: 4352883 (1982-10-01), Lim
patent: 4373527 (1983-02-01), Fischell
patent: 4387715 (1983-06-01), Hakim et al.
patent: 4551128 (1985-11-01), Hakim et al.
patent: 4595390 (1986-06-01), Hakim et al.
patent: 4615691 (1986-10-01), Hakim et al.
patent: 4642120 (1987-02-01), Nevo et al.
patent: 4904259 (1990-02-01), Itay
patent: 5041138 (1991-08-01), Vacanti et al.
patent: 5053050 (1991-10-01), Itay
patent: 5108753 (1992-04-01), Kuberasampath et al.
patent: 5283187 (1994-02-01), Aebischer et al.
patent: 5464929 (1995-11-01), Bezwada et al.
patent: 5468253 (1995-11-01), Bezwada et al.
patent: 5554148 (1996-09-01), Aebischer et al.
patent: 5595751 (1997-01-01), Bezwada et al.
patent: 5597579 (1997-01-01), Bezwada et al.
patent: 5607687 (1997-03-01), Bezwada et al.
patent: 5618552 (1997-04-01), Bezwada et al.
patent: 5620698 (1997-04-01), Bezwada et al.
patent: 5645850 (1997-07-01), Bezwada et al.
patent: 5648088 (1997-07-01), Bezwada et al.
patent: 5698213 (1997-12-01), Jamiolkowski et al.
patent: 5700583 (1997-12-01), Jamiolkowski et al.
patent: 5842477 (1998-12-01), Naughton et al.
patent: 5855619 (1999-01-01), Caplan et al.
patent: 5859150 (1999-01-01), Jamiolkowski et al.
patent: 5869041 (1999-02-01), Vandenburgh
patent: 5872094 (1999-02-01), Goetinck et al.
patent: 5902745 (1999-05-01), Butler et al.
patent: 5939323 (1999-08-01), Valentini et al.
patent: 5968502 (1999-10-01), Treco et al.
patent: 5980508 (1999-11-01), Cardamone et al.
patent: 6001352 (1999-12-01), Boyan et al.
patent: 6008013 (1999-12-01), Reynolds
patent: 6013853 (2000-01-01), Athanasiou et al.
patent: 6048729 (2000-04-01), Selden et al.
patent: 6054288 (2000-04-01), Selden et al.
patent: 6103528 (2000-08-01), An et al.
patent: 6149902 (2000-11-01), Artavanis-Tsakonas et al.
patent: 6165225 (2000-12-01), Antanavich et al.
patent: 6224893 (2001-05-01), Langer et al.
patent: 6261584 (2001-07-01), Peery et al.
patent: 6303379 (2001-10-01), Selden et al.
patent: 6306169 (2001-10-01), Lee et al.
patent: 6361771 (2002-03-01), Tao et al.
patent: 6365149 (2002-04-01), Vyakarnam et al.
patent: 6387693 (2002-05-01), Rieser et al.
patent: 6395292 (2002-05-01), Peery et al.
patent: 6410313 (2002-06-01), Kasahara et al.
patent: 6413511 (2002-07-01), Glorioso et al.
patent: 6455304 (2002-09-01), Weigel et al.
patent: 6458889 (2002-10-01), Trollsas et al.
patent: 6472181 (2002-10-01), Mineau-Hanschke
patent: 6548249 (2003-04-01), Anderson et al.
patent: 6635268 (2003-10-01), Peery et al.
patent: 7149587 (2006-12-01), Wardle et al.
patent: 2001/0002392 (2001-05-01), Heinegard et al.
patent: 2001/0014475 (2001-08-01), Frondoza et al.
patent: 2001/0033857 (2001-10-01), Vyakarnam et al.
patent: 2001/0037017 (2001-11-01), Luyten et al.
patent: 2001/0051834 (2001-12-01), Frondoza et al.
patent: 2002/0003727 (2002-01-01), Hartmann
patent: 2002/0006428 (2002-01-01), Mahmood et al.
patent: 2002/0009477 (2002-01-01), Mahmood et al.
patent: 2002/0037279 (2002-03-01), Vandenburgh
patent: 2002/0076810 (2002-06-01), Radice et al.
patent: 2002/0094569 (2002-07-01), Yu et al.
patent: 2002/0110544 (2002-08-01), Goldberg et al.
patent: 2002/0115218 (2002-08-01), Havenga et al.
patent: 2002/0142984 (2002-10-01), Brigham et al.
patent: 2002/0160471 (2002-10-01), Kisiday et al.
patent: 2002/0177224 (2002-11-01), Madry et al.
patent: 2003/0012805 (2003-01-01), Chen et al.
patent: 2003/0036523 (2003-02-01), Czichos et al.
patent: 2003/0064088 (2003-04-01), Carvalho et al.
patent: 2003/0077260 (2003-04-01), Mineau-Hanschke
patent: 2003/0167054 (2003-09-01), Rosenberg et al.
patent: 2005/0054595 (2005-03-01), Binette et al.
patent: 2005/0191301 (2005-09-01), Heavner et al.
patent: 2006/0292131 (2006-12-01), Binette et al.
patent: 2008/0181954 (2008-07-01), Binette et al.
patent: 62198388 (1987-09-01), None
patent: 62269697 (1987-11-01), None
patent: 96/34955 (1996-11-01), None
patent: 96/39196 (1996-12-01), None
patent: 99/11789 (1999-03-01), None
patent: 0014261 (2000-03-01), None
patent: 02/074912 (2002-09-01), None
patent: 03/082302 (2003-10-01), None
patent: 03084477 (2003-10-01), None
Griscelli et. al., (1998) proc. Natl. Acad. Sci., USA 95: 6367.
Hearing et. al., (1986) J. Immunol., 137: 379.
Carson et. al., (1998) J. Surg. Res., 75: 97.
Maurer-Gebhard et. al., (1998) Cancer Res., 58: 2661.
Takaori-Kondo et. al., (1998) Blood, 91: 4747.
Greiss et. al., (1993) Biophysical J., 65: 138-148.
Jorgensen at al. (Immunology Today Trends. Sep. 1998; 19(9): 387-391).
Uludag et al. (Advanced Drug Delivery Reviews. 2000; 42: 29-64).
Grogan, et al., “Engineering Cartilage for Drug Delivery,” Institute of Pathology, University of Bern, Murtenstrasse 31, 3010, Bern Switzerland.
Golab et. al., (1998) Ann. Oncol., 9: 63.
Bookman et. al., (1998) Semin. Oncol., 25: 381.
Steinert et al. “Arthritis Research & Therapy,” 2007, vol. 9. No. 213, pp. 1-15.
Weitzman, Annu. Rev. Biochem, 2005, vol. 74, pp. 711-738.
Farnum C E, Lee R, O'Hara K, Urban J P G; Volume increase in growth plate chondrocytes during hypertrophy: the contribution of organic osmolytes. Bone 2002;30(4):574-81.
International Search Report and Written Opinion for PCT/US2008/064481 dated Sep. 23, 2008.
Madry, et al., “Efficient lipid-mediated gene transfer to articular chondrocytes,” Feb. 2002, Gene Therapy, vol. 7, No. 4, pp. 286-291.
Himeno, et al., “Impaired Vascular Invasion of CBFA1-Deficient Cartilage Engrafted in the Spleen,” Jul. 2002, Journal of Bone and Mineral Research, vol. 17, No. 7, pp. 1297-1305.
Arai, et al., “Adenovirus Vector-Mediated Gene Transduction to Chondrocytes: In Vitro Evaluation of Therapeutic Efficacy of Transforming Growth Factor-Beta1 and Heat Shock Protein 70 Gene Transduction,” 1997, Journal of Rheumatology, vol. 24, pp. 1787-1795.
Bartholomew, et al., “Baboon mesencymal stem cells can be genetically modified to secrete hum erythropoietin in vovi,” Aug. 2001, Human Gene Therapy, vol. 12, No. 12, pp. 1527-1541.
Okada et al (Biol. Pharm. Bull. 1997. vol. 20, No. 3, pp. 255-258).
Leboy et al., (1989) J. Biol. Chem., 264: 17281-17286.
Sullivan et. al., (1994) J. Biol. Chem., 269: 22500-22506.
Bohme et. al., (1995)Exp. Cell Res., 216: 191-198.
Lian et. al., (1993) J. Cellular Biochem., 52: 206-219.
Roark et. al., (1994) Develop. Dynam., 200: 103-116.
Downie et. al., (1994) Dev. Biol., 162: 195.
Rosselot et. al., (1994) J. Bone Miner. Res., 9: 431-439.
Gelb et. al., (1990) Endocrinology, 127: 1941-1947.
Crabb et. al., (1990) J. Bone Mineral Res., 5: 1105-1112.
Kato et. al., (1998) Proc. Nat. Acad. Sci., 85: 9552-9556.
Bohme et. al., (1992) Prog. Growth Factor res., 4: 45-68.
Leboy et. al., (1994) Microscopy Res. and Technique 28: 483-491.
Iwamoto et. al., (1993) Exp. Cell Res., 207: 413-420.
Iwamoto et. al., (1993) Exp. Cell Res. 205: 213-224.
Pacifici et. al., (1991) Exp. Cell Res. 195: 38-46.
Shapiro et. al., (1994) J. Bone Min. Res., 9: 1229-1237.
Corvol et. al., (1980) FEBS Lett., 116: 273-276.
Gerstenfeld et. al., (1990) Conn. Tiss. Res. 24: 29-39.
Schwartz et. al., (1989) J. Bone Miner. Res. 4: 199-207.
Suda, (1985) Calcif Tissue Int, 37: 82-90.
Isacson et. al., (1985) Neuroscience 16: 799-817.
Kanazawa et. al., (1986) Neurosci. Lett., 71: 241-246.
Hantraye et. al., (1992) Proc. Natl. Acad. Sci., USA 89: 4187-4191.
Hantraye et. al., (1990) Exp. Neurol., 108: 91-1014.
Isacson et. al., (1989) Exp. Brain Res., 75(1): 213-

Affiliated with

Also associated with

Rating

Chondrocyte therapeutic delivery system does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Chondrocyte therapeutic delivery system, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chondrocyte therapeutic delivery system will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2668374